Major GSK Country definition

Major GSK Country means any of [ * ]
View Source
Major GSK Country means each of the following: Brazil, Mexico, People’s Republic of China, South Africa, South Korea, Taiwan and Turkey.
View Source
Major GSK Country means each of the following: Brazil, Mexico, People’s Republic of China, South Africa, South Korea, Taiwan and Turkey. *** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
View Source

Examples of Major GSK Country in a sentence

  • Without limiting the provisions of Section 4.1, GSK shall file a MAA in (a) each Major GSK Country (other than the People’s Republic of China) within three (3) years after the Effective Date and (b) the People’s Republic of China within four (4) years after the Effective Date.

  • In addition, to the extent that GSK or a GSK Affiliate is then manufacturing Licensed Products for the GSK Territory or Major GSK Country, as applicable, GSK shall continue to manufacture Licensed Products for Gilead's use in the GSK Territory or Major GSK Country, as applicable, for [ * ], as applicable, in addition to that which it had in place for its use outside the GSK Territory.

  • GSK shall also provide such assistance, [ * ], as may be reasonably necessary to transfer and/or transition over a reasonable period of time to Gilead [ * ] in the GSK Territory or Major GSK Country, as applicable, to the extent [ * ], including without limitation [ * ]in the GSK Territory or Major GSK Country, as applicable.

  • To the extent that any [ * ] for the ▇▇▇ ▇▇▇▇▇▇▇▇▇ or Major GSK Country, as applicable, is [ * ], then GSK shall reasonably cooperate with Gilead to [ * ] to Gilead.

  • In addition, GSK shall launch the Licensed Products (i) within [***] after the date of receipt of Marketing Authorization in each Major GSK Country and (ii) within [***] of receipt of Marketing Authorization in each other country in the GSK Territory, but in the case of (i) and (ii) no later than [***] after the Effective Date.

  • Without limiting the provisions of Section 4.1, GSK shall file a MAA in (a) each Major GSK Country (other than [***]) within [***] after the Effective Date and (b) [***] within [***] after the Effective Date.

  • GSK shall discontinue making any representation regarding its status as a licensee of or distributor for Gilead in the GSK Territory or Major GSK Country, as applicable, for all Reverted Products, and shall cease conducting any activities with respect to the marketing, promotion, sale or distribution of the Reverted Product in the GSK Territory, or Major GSK Country, as applicable.